Header Logo

Connection

AHMED ELKHANANY to Bridged-Ring Compounds

Back to Details
This is a "connection" page, showing publications AHMED ELKHANANY has written about Bridged-Ring Compounds.
AHMED ELKHANANY
Connection Strength
0.061
Bridged-Ring Compounds
  1. Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study. JCO Precis Oncol. 2026 Jun; 10(6):e2501285.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.